Inflammatory bowel disease (IBD) has a multifaceted pathology and varying presentation, which can result in complicated treatment decisions, especially in patients with refractory disease where available options may be limited. Recent progress in disease management has resulted in improvements in therapeutic monitoring, the detection of novel inflammatory and immunologic targets, and related investigational agents for treating patients with IBD. Successful use of these treatment protocols and newer agents will hinge primarily on clinician awareness about how they differ from traditional options, how each type of treatment relates to the pathophysiology of IBD, and where each treatment and protocol fit in to the evolving treatment spectrum.
In this activity, you will be presented with 5 case-based questions/scenarios regarding traditional and newer treatments for patients with IBD, based on information presented at Digestive Disease Week (DDW) 2015. You will also be able to see how your results compare with those of your peers.
The goal of this activity is to illustrate the current key concepts in the treatment and management of patients with IBD presented at DDW 2015.
This activity is designed for gastroenterologists and other primary providers of care for patients with IBD. No prerequisites required.
Gary R. Lichtenstein, MD (Course Director)
Professor of Medicine
Raymond and Ruth Perelman School of Medicine
of the University of Pennsylvania
Director, Center for Inflammatory Bowel Disease
Department of Medicine
Division of Gastroenterology
David T. Rubin, MD, AGAF
The Joseph B. Kirsner Professor of Medicine
Chief, Section of Gastroenterology, Hepatology, and Nutrition
Co-Director, Digestive Diseases Center
The University of Chicago Medicine
Asher A. Kornbluth, MD
Clinical Professor of Medicine
Clinical Research Director, the Sanford J. Grossman Integrative Center for the Study of IBD
The Inflammatory Bowel Disease Center
The Henry D. Janowitz Division of Gastroenterology
Mount Sinai School of Medicine
New York, New York
There is no fee for this educational activity.
Rapid Fire: IBD
Gary R. Lichtenstein, MD, David T. Rubin, MD, AGAF, and Asher A. Kornbluth, MD